Hannover, Germany

Bernd Boedecker

USPTO Granted Patents = 2 


Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bernd Boedecker: Innovator in Pharmaceutical Compositions

Introduction

Bernd Boedecker is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance lipolytic activity. His work focuses on addressing maldigestion issues, especially those arising from chronic exocrine pancreatic insufficiency.

Latest Patents

Boedecker holds two patents that showcase his innovative approach. The first patent involves pharmaceutical compositions of lipase-containing products, specifically pancreatin. These orally administrable compositions are designed to improve lipolytic activity and stabilize lipase in acidic pH environments. The second patent details the preparation of pancreatin micropellets, which are coated with a gastric juice-resistant film. These micropellets are created through a meticulous process that ensures they maintain their efficacy and stability.

Career Highlights

Throughout his career, Bernd Boedecker has worked with prominent companies such as Kali-Chemie Pharma GmbH and Abbott Products GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective treatments.

Collaborations

Some of his notable coworkers include Friederike Henninges and Klaus-Juergen Koelln. Their collaborative efforts have further advanced the research and development of pharmaceutical compositions.

Conclusion

Bernd Boedecker's contributions to the field of pharmaceuticals, particularly in the area of lipase-containing products, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to addressing significant medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…